November 19, 2024 C-Path’s TRxA Announces $1 Million Award for Drug Development Project in Type 1 Diabetes C-Path today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership...
November 17, 2024 Advancing Neonatal Drug Development: Celebrating Progress on World Prematurity Day On this occasion of World Prematurity Awareness Day, we reflect on the immense progress we have made together and recognize...
November 14, 2024 Advanced in Vitro Modelling of Neuromuscular Diseases and Therapeutics Join this webinar to explore innovative, multidisciplinary approaches in disease modeling, drug testing, and tissue engineering...
November 14, 2024 C-Path’s Initiative to Optimize Clinical Trial Design in New-Onset Type 1 Diabetes In honor of World Diabetes Day and the need to improve diabetes treatment, Critical Path Institute’s Type 1 Diabetes Consortium
November 13, 2024 C-Path Announces Global Evidence in Medicine for Parkinson’s Disease (GEM‑PD) Initiative C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden..
November 7, 2024 C-Path Announces Key Leadership Appointments in Neurodegenerative Disease Research Dr. Diane Stephenson Promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as New Executive Director of CPAD.
November 6, 2024 The Path to Accessibility: Installing ADA-Friendly Solutions When C-Path launched its new website, it was built to be sleek, mobile, responsive and navigable.
October 29, 2024 Webinar: New Findings on Inequities in Rare Diseases: How They Impact Research and Clinical Trials Processes Join us Tuesday, October 29, at noon Eastern for an important webinar, New Findings on Inequities in Rare Diseases...
October 16, 2024 ADHD Awareness Month: Addressing Disparities in Diagnosis and Treatment October is ADHD Awareness Month, dedicated to raising awareness about Attention Deficit Hyperactivity Disorder (ADHD) and
October 16, 2024 Sanford Health Rare Disease Data Registry and C-Path’s RDCA-DAP Enter into a Master Data Contribution Agreement to Aggregate Rare Disease Data Critical Path Institute (C-Path) is pleased to announce the expansion of our partnership with the Coordination...